Global Dementia Drugs Market Insights, Forecast to 2025

The global Dementia Drugs market is valued at 13900 million US$ in 2018 and will reach 26500 million US$ by the end of 2025, growing at a CAGR of 8.4% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Dementia Drugs market based on company, product type, end user and key regions.

This report studies the global market size of Dementia Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Dementia Drugs in these regions.

This research report categorizes the global Dementia Drugs market by top players/brands, region, type and end user. This report also studies the global Dementia Drugs market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

Get Free Sample Copy Of This Report @

The following manufacturers are covered in this report, with sales, revenue, market share for each company:

Eisai, Inc

Janssen Pharmaceuticals, Inc

Biogen Pharmaceuticals

Forest Laboratories, Inc

Eli Lilly and Company

Novartis AG

Sanofi S.A

AstraZeneca GmbH

F. Hoffmann-La Roche

Merck & Co., Inc

Valeant Pharmaceutical International

Pfizer Inc

Teva Pharmaceuticals Industries

Market size by Product

MAO Inhibitors

Cholinesterase Inhibitors

Glutamate Inhibitors

Market size by End User

Hospital Pharmacies

Retail Pharmacies


Market size by Region

North America

United States







South Korea















Central & South America


Rest of Central & South America

Middle East & Africa

GCC Countries



South Africa

Request For Enquiry @

The study objectives of this report are:

To study and analyze the global Dementia Drugs market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.

To understand the structure of Dementia Drugs market by identifying its various subsegments.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

Focuses on the key global Dementia Drugs companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.

To project the value and sales volume of Dementia Drugs submarkets, with respect to key regions.

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Dementia Drugs are as follows:

History Year: 2014-2018

Base Year: 2018

Estimated Year: 2019

Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Dementia Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

Contact Us:


State Tower

90 Sate Street, Suite 700

Albany, NY 12207

Tel: +1-518-621-2074

US-Canada Toll Free: 866-997-4948



Follow Us On: